PRWeb.com Press Release Feed - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/120371.xml PRWeb.com Press Release Feed - Press Releases en xml@emediawire.com xml@emediawire.com 30 Key HIV/AIDS Drug Patents To Be Reviewed By U.S. Patent Office http://www.prweb.com/releases/2007/07/prweb540407.htm The Public Patent Foundation ("PUBPAT") announced today that the U.S. Patent & Trademark Office has granted each of PUBPAT's requests to review four key HIV/AIDS drug patents held by Gilead Sciences, Inc. The patents relate to the drug known generically as tenofovir disoproxil fumarate (TDF), a key weapon in the battle against HIV/AIDS. Gilead markets TDF in the United States under the brand name VIREAD and as a part of its ATRIPLA combination product. Prior Art Submitted by PUBPAT Raises Substantial Doubt Regarding Validity of Gilead Sciences Claims. (PRWeb Jul 18, 2007)

Read the full story at http://www.prweb.com/releases/2007/07/prweb540407.htm

]]> Wed, 18 Jul 2007 07:00:00 GMT http://www.prweb.com/releases/2007/07/prweb540407.htm PUBPAT Challenges EpicRealm Patents Being Asserted Against Providers of Dynamic Websites http://www.prweb.com/releases/2006/11/prweb482072.htm The Public Patent Foundation ("PUBPAT") filed formal requests with the United States Patent and Trademark Office to review two patents held by epicRealm Licensing Inc. that the patent licensing company - which offers no product or service - is widely asserting against providers of dynamic websites, i.e. websites that can produce custom responses to individual visitors or users. In its filings, PUBPAT submitted prior art that the Patent Office was not aware of when reviewing the applications that led to the two patents, described in detail how the prior art invalidates the patents and asked that the patents be revoked. (PRWeb Nov 22, 2006)

Read the full story at http://www.prweb.com/releases/2006/11/prweb482072.htm

]]> Wed, 22 Nov 2006 08:00:00 GMT http://www.prweb.com/releases/2006/11/prweb482072.htm PUBPAT Challenges Monsanto Patents Being Used to Bankrupt American Farmers http://www.prweb.com/releases/2006/09/prweb444428.htm The Public Patent Foundation ("PUBPAT") filed formal requests with the United States Patent and Trademark Office today to reexamine four of Monsanto Corporation's patents related to genetically modified crops that the agricultural giant is using to sue - and in some cases literally bankrupt - American farmers. (PRWeb Sep 29, 2006)

Read the full story at http://www.prweb.com/releases/2006/09/prweb444428.htm

]]> Fri, 29 Sep 2006 07:00:00 GMT http://www.prweb.com/releases/2006/09/prweb444428.htm Forgent Networks Patent Asserted Against JPEG Standard Rejected by Patent Office as Result of PUBPAT Request http://www.prweb.com/releases/2006/05/prweb390790.htm In the reexamination proceeding initiated late last year by the Public Patent Foundation ("PUBPAT"), the United States Patent and Trademark Office has rejected the broadest claims of the patent Forgent Networks (NASDAQ: FORG) is asserting against the Joint Photographic Experts Group (JPEG) international standard for the electronic sharing of photo-quality images. In its Office Action released yesterday, the Patent Office found that the prior art submitted by PUBPAT completely anticipated the broadest claims of the patent, U.S. Patent No. 4,698,672 (the '672 Patent)." (PRWeb May 26, 2006)

Read the full story at http://www.prweb.com/releases/2006/05/prweb390790.htm

]]> Fri, 26 May 2006 07:00:00 GMT http://www.prweb.com/releases/2006/05/prweb390790.htm Patent Asserted Against JPEG Standard to be Reexamined at PUBPAT Request: Patent Office Finds 'Substantial Question' Regarding the Validity of Forgent Networks' Widely Asserted Patent http://www.prweb.com/releases/2006/02/prweb341104.htm The United States Patent and Trademark Office has granted the Public Patent Foundation's ("PUBPAT's") request for a reexamination of the patent Forgent Networks Inc. is widely asserting against the Joint Photographic Experts Group (JPEG) international standard for the electronic sharing of photo-quality images. In its Order granting PUBPAT's request, the Patent Office found that PUBPAT raised "a substantial new question of patentability" regarding every claim of the patent, U.S. Patent No. 4,698,672 (the '672 Patent). (PRWeb Feb 2, 2006)

Read the full story at http://www.prweb.com/releases/2006/02/prweb341104.htm

]]> Thu, 02 Feb 2006 08:00:00 GMT http://www.prweb.com/releases/2006/02/prweb341104.htm Pubpat Challenges Data Compression Patent To Protect Jpeg Format: Patent Office Provided New Evidence Proving Patent Asserted Against International Standard Is Invalid http://www.prweb.com/releases/2005/11/prweb311576.htm The Public Patent Foundation ("PUBPAT") filed a formal request with the United States Patent and Trademark Office today to revoke Compression Labs Inc.'s patent on data compression that the company is widely asserting against an international standard for the electronic sharing of photo-quality images. In its filing, PUBPAT submitted previously unseen prior art showing that the patent, which was issued in 1987, was not new and, as such, should be revoked. (PRWeb Nov 16, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb311576.htm

]]> Wed, 16 Nov 2005 08:00:00 GMT http://www.prweb.com/releases/2005/11/prweb311576.htm Patent Office Rejects Lipitor Patent on PUBPAT's Request: Public Interest Group's Review Results in All 44 Claims of Pfizer's Patent on Multi-Billion Dollar Drug Ruled Invalid http://www.prweb.com/releases/2005/06/prweb254102.htm In the reexamination proceeding initiated late last year by the Public Patent Foundation ("PUBPAT"), the United States Patent and Trademark Office has rejected all of the claims of Pfizer Inc.'s patent on Lipitor, touted by the pharmaceutical giant as being "the best-selling treatment for lowering cholesterol and the best-selling pharmaceutical product of any kind in the world." (PRWeb Jun 22, 2005)

Read the full story at http://www.prweb.com/releases/2005/06/prweb254102.htm

]]> Wed, 22 Jun 2005 07:00:00 GMT http://www.prweb.com/releases/2005/06/prweb254102.htm U.S. Congress Invites PUBPAT Executive to Testify about Patent Reform http://www.prweb.com/releases/2005/06/prweb249103.htm The Public Patent Foundation ("PUBPAT") announced today that Executive Director, Dan Ravicher, has been invited by the U.S. House of Representatives to testify at this week's hearing on a proposed bill to reform the patent system. Ravicher will make a presentation and then answer questions from Representatives on the Subcommittee on Courts, the Internet, and Intellectual Property, including Chairman Lamar Smith (R-TX) and Ranking Member Howard Berman (D-CA), at the hearing scheduled for 9:00 am EDT on Thursday, June 9, 2005. (PRWeb Jun 8, 2005)

Read the full story at http://www.prweb.com/releases/2005/06/prweb249103.htm

]]> Wed, 08 Jun 2005 07:00:00 GMT http://www.prweb.com/releases/2005/06/prweb249103.htm PUBPAT Releases Free "Finding Prior Art for an Issued Patent" Program http://www.prweb.com/releases/2005/05/prweb239622.htm The Public Patent Foundation ("PUBPAT") released a free program today that details how to find prior art for issued patents. The hour long audio recording with supporting written materials uses a model patent as the basis for examples during the session. PUBPAT's program is made available as part of the organization's ongoing efforts to inform the public and provide advocacy about the patent system. (PRWeb May 12, 2005)

Read the full story at http://www.prweb.com/releases/2005/05/prweb239622.htm

]]> Thu, 12 May 2005 07:00:00 GMT http://www.prweb.com/releases/2005/05/prweb239622.htm Pubpat Argues Against Patenting of Medical Facts: Urges Solicitor General to Do Same in Appeal Pending at Supreme Court http://www.prweb.com/releases/2005/03/prweb222875.htm The Public Patent Foundation ("PUBPAT") released a position statement today arguing against the issuance of patents on medical facts that prevent doctors from using those facts to treat their patients or discuss those facts with colleagues. (PRWeb Mar 29, 2005)

Read the full story at http://www.prweb.com/releases/2005/03/prweb222875.htm

]]> Tue, 29 Mar 2005 08:00:00 GMT http://www.prweb.com/releases/2005/03/prweb222875.htm PUBPAT Questions Objectiveness and Openness of "Town Hall" Meetings on Patent Reform http://www.prweb.com/releases/2005/02/prweb210571.htm The Public Patent Foundation ("PUBPAT") has questioned the objectiveness and openness of today's "Town Hall" meeting on patent reform held in San Jose, CA and the future "Town Hall" meetings on patent reform to be held March 4 in Chicago and March 18 in Boston. (PRWeb Feb 19, 2005)

Read the full story at http://www.prweb.com/releases/2005/02/prweb210571.htm

]]> Sat, 19 Feb 2005 08:00:00 GMT http://www.prweb.com/releases/2005/02/prweb210571.htm Lipitor Patent To Be Reexamined At PUBPAT's Request: Patent Office Agrees There is a "Substantial Question" Regarding Blockbuster Cholesterol-Lowering Drug Patent's Validity http://www.prweb.com/releases/2004/12/prweb186752.htm The United States Patent and Trademark Office has issued an Order granting the Public Patent Foundation's Request for Reexamination of Pfizer's patent on Lipitor, touted by the pharmaceutical giant as being "the best-selling treatment for lowering cholesterol and the best-selling pharmaceutical product of any kind in the world." In its Order, the Patent Office found that PUBPAT's request raised "a substantial new question of patentability" regarding all 44 claims of the patent. (PRWeb Dec 8, 2004)

Read the full story at http://www.prweb.com/releases/2004/12/prweb186752.htm

]]> Wed, 08 Dec 2004 08:00:00 GMT http://www.prweb.com/releases/2004/12/prweb186752.htm